The HERITAGE study (Health Effects fRom Infection sequelae: Tailoring services and Advancing GuidancE)

What got me is the lack of respect for participants.

If I was advising on this, I would insist on:

Clear indication of which study this is a reminder for.
A welcome note, thanking the participant for their previous effort
Not declaring that "Your XXX assessment is due today". The study is not due my input at any time, it gets it when I'm able.
No duplicate effort needed from the participant
Link(s) back to the study page and/or contact information in case the participant needs it

To try to be overly fair, perhaps the app doesn't allow for any of that, but if that is the case, it is not fit for purpose, so the research team shouldn't have chosen to use it. If the research team aren't prepared to deal with their participants with respect, then I have no faith that they will treat my data with respect.
 
The app is completely uninfomative.

The home page tells me I have 1 assessment due today and has been saying that whenever it's occured to me occasionally to see if there's anything new on the app over the months. When I select that button, nothing happens.

The My Health page tells me to complete assessments assigned to me, but that also doesn't tell me any more or take me to any assignments.

I can access my history which lists and links me to the questionnaires I filled in over 3 months ago.

Maybe when it decides my 3 months are up it will give me the links to the questionnaires. Or maybe not, who knows. I can't be bothered trying to find out. The questionnaires are useless anyway.
 
This is a project the UKNIHR has spent over a million pounds on. I'm disgusted and minded to make a complaint to NIHR and ask them to withdraw the rest of the funding
Deeply frustrated with this; I couldn't work out if I was eligible or not.

I think not, as I have had two phonecalls with the local long covid assessment service (that was too far away for me to drive to)

They told my GP I needed "holistic mental health support" which confused us both, and also signposted me to CBT for insomnia.my issue isn't insomnia; it's ADHD induced bedtime procrastination.

So I think that disqualifies me from taking part in this extremely selective and completely unrepresentative study.

Writing to complain sounds like a good idea.

Are you writing a template email @Trish ? DM me if you want to collaborate.
 
This is a project the UKNIHR has spent over a million pounds on. I'm disgusted and minded to make a complaint to NIHR and ask them to withdraw the rest of the funding. The whole thing is a farce.
I agree Trish. Thank you (and JellyBabyKid) for taking this on. A complaint from you and/or collectively from UK members of S4ME would be so welcome.

The costing of HERITAGE is genuinely shocking. An existing app, mostly existing surveys, predominantly self-selecting participants….

Moreover, as others have said, this project will not generate meaningful data and is a slap in the face for patients. It would be a waste of money if it had been done for £2.50. Like many others I signed up but gave up when it was clear it was not accessible to me. Whomever they are surveying, it isn’t severely affected patients. The abrasive tone of the survey engine emphasises this project’s disregard of patient needs and is the icing on this unpalatable cake.

If any scientific luminaries on here are able to have a private word with senior people at NIHR, to back you up Trish, that would be helpful. A complaint, no matter how well founded, will likely be dismissed without proper consideration. But if it provides a route for the flaws in this project to get through to the right people, there could at least be some institutional learning from this.
 
From the NIHR website:
https://fundingawards.nihr.ac.uk/award/NIHR174857

Research Award​

Active Award​

Award ID: NIHR174857​

Shortlist:

Health Effects fRom Infection sequelae: Tailoring services and Advancing GuidancE (HERITAGE) in Long Covid and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome​

Plain English Summary:

BACKGROUND:
Persistent Long covid (LC) or post-COVID syndrome, defined as LC present for > 2 years and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are long-term conditions that together affect > 1.5 million people in the UK alone and > 60 million worldwide. Both conditions have significant overlapping symptoms, are linked to infections, and have some common underlying pathophysiology.

The burden to the UK economy per year is estimated to be £8.1 billion for LC and £3.3 billion for ME/CFS. These two conditions are nevertheless not adequately prioritised by National Health Service (NHS) services (many LC clinics are closing, and many UK areas lack ME/CFS clinics) and lack research funding. There is an urgent need for health services research and developing a National Service Framework that will improve care in existing services and effectively reduce the overall costs to the NHS and the UK economy.

In the NIHR-funded health services LOCOMOTION study (2021-2024), we acquired expertise, skills and databases in LC that will help deliver HERITAGE at a lower cost to funder and maximise the opportunity to develop a National Service Framework for ME/CFS and LC.

AIMS AND OBJECTIVES: The study in ME/CFS and LC aims to: 1) explore the overlap, long-term trajectory of symptoms, and clinical outcomes; 2) assess the healthcare utilisation and cost-effectiveness of different service models (including analysing costs and outcomes in a national cohort with no access to clinics); 3) develop a national service framework to improve quality of care in both conditions

METHODS:

WP1: Map the clinical course and health costs over 12 months in persistent LC (1250 patients complete datasets) and ME/CFS (250 patients) via our validated DPROM platform from three established sites (with different integration models) and a non-clinic national cohort (who have either no access to specialist clinic or no clinics in their area);

WP2: estimate the cost-effectiveness of three service models and also compare to UK-wide non-clinic cohort using validated PROMs for LC and ME/CFS, EQ5D-5L, healthcare utilisation, vocational productivity loss, carer burden and Quality Adjusted Life Year (QALY) estimates; and

WP3: exploring quality of care using qualitative interviews and set up a Quality Improvement Collaborative (QIC) to improve care in both conditions informed by the principles of action research and generate training resources and transferable lessons for a National Service Framework for ME/CFS and LC.

PPI: The HERITAGE bid was co-developed with a diverse group of UK-wide lived-experience patients from both conditions, charities, and policymakers. The PPI team will be equal partners in research, co-produce research outputs, and help engage stakeholders.

IMPACT AND DISSEMINATION:
HERITAGE will inform the development of evidence-based, cost-effective NHS service models for LC and ME/CFS. The national service framework will improve quality of life, reduce vocational disability, reduce economic burden, and potentially be applicable to other post-infection syndromes and strengthen our pandemic preparedness. Dissemination will be via our already established channels with all UK LC and ME/CFS clinics, the National Post-Covid Society (CPCS), World Health Organisation, All Party Parliamentary Groups (APPG), NHS Integrated Care Boards (ICBs), patient charities, and research funders.

Abstract:

One million individuals in the UK have the long-term condition of Long COVID (symptoms for more than 2 years). Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) is estimated to affect half a million UK people. These two conditions are related to infections, have overlapping symptoms that include severe fatigue, post-exertional malaise, cognitive problems, unrefreshing sleep, chronic pain, problems in daily activities and work.

The total health and social care costs, including lost productivity, caregiver costs, and value of lost health, are estimated to be £8.1 billion/ year for Long COVID and £3.3 billion/year for ME/CFS.

Both conditions are not prioritised by clinicians and researchers, are currently treated in disjointed services, and many individuals have no access to specialist clinics.
There's a need for research to improve the quality of existing specialist services, introduce new services, and enable better care for all individuals affected by these common long-term conditions.

Our previous study LOCOMOTION (2021-2024) funded by the NIHR for Long COVID enabled us to develop skills in standardising and improving quality of care, test a digital platform for collecting outcomes and analyse healthcare costs; these skills and resources can now be applied in this proposal (HERITAGE) to enable best value for money for the funder.

Aims of the HERITAGE study

1. To understand how the symptoms of Long COVID and ME/CFS overlap, and progress over time
2. To capture healthcare costs and carer burden and discover which of the current healthcare models (No specialist care or LC/ ME/CFS specialist care) are the best value for money
3. To improve the quality of Long COVID and ME/CFS healthcare and ensure the best standard of care is available to all nationally

How the study will be done

Work Package 1 (WP1): Use our existing digital platform to collect data on how ME/CFS and Long COVID are diagnosed by healthcare professionals, their symptoms and how much the two conditions overlap and affect people over time.

WP2: Compare the costs and effectiveness of the different existing service models in terms of integration between Long COVID and ME/CFS clinics (including comparing with healthcare, economic and societal costs in a separate UK-wide group having no access to specialist clinics).

WP3: Talk to patients, healthcare workers, and other stakeholders to understand what's working well and what needs to change, and how to address systemic barriers of stigma, disbelief, race, culture and social deprivation.

HERITAGE will develop a national system of services and offer training and resources for all specialist services and primary care across the UK.

Patient and Public Involvement (PPI)
The proposal has already involved people with lived experience of Long COVID and ME/CFS from a wide range of backgrounds and UK locations. This group will continue to shape every aspect of the study from start to finish. A dedicated research inclusion group will ensure a range of voices are heard.

Dissemination and Stakeholder Engagement
The study findings will be shared with healthcare organisations, including the Department of Health, national clinical and research networks, NHS services, Integrated Care Boards, and relevant All-Party Parliamentary Groups. Impact This research will improve healthcare for an estimated 1.5 million people in the UK, and determine high-quality, cost-effective service provision for Long COVID and ME/CFS

Chief Investigator(s):
Professor Manoj Sivan
Co-investigators:
Dr Darren Greenwood, Dr Gemma Hughes, Dr Harsha Master, Dr Joseph Kwon, Dr Stephen Halpin, Dr Vikki McKeever, Professor Rachael Evans Professor Stavros Petrou
Award:
£1,389,206.23
Programme:
Health and Social Care Delivery Research
Health Category(s):
Infection, Other
Research Activity(s):
8.1 Organisation and delivery of services

Start Date:
January 2026
End Date:
June 2028
Contracting Organisation:
University of Leeds
Research Call:
HSDR Researcher-led call (November 24 - March 25)
Programme Stream:
Researcher Led
Funding Stream:
HSDR Researcher
 
IMPACT AND DISSEMINATION:
HERITAGE will inform the development of evidence-based, cost-effective NHS service models for LC and ME/CFS. The national service framework will improve quality of life, reduce vocational disability, reduce economic burden, and potentially be applicable to other post-infection syndromes and strengthen our pandemic preparedness. Dissemination will be via our already established channels with all UK LC and ME/CFS clinics, the National Post-Covid Society (CPCS), World Health Organisation, All Party Parliamentary Groups (APPG), NHS Integrated Care Boards (ICBs), patient charities, and research funders.
Bold claims, particularly given Andy and Trish's experiences thus far.

Dissemination and Stakeholder Engagement
The study findings will be shared with healthcare organisations, including the Department of Health, national clinical and research networks, NHS services, Integrated Care Boards, and relevant All-Party Parliamentary Groups. Impact This research will improve healthcare for an estimated 1.5 million people in the UK, and determine high-quality, cost-effective service provision for Long COVID and ME/CFS

Given that this study is referred to in the ME/CFS Final Delivery Plan and will be informing the National Service Framework, (DHSC's "own work"), if you receive no response from the research team to your complaint (s), you could escalate it/them to the Department of Health and Social Care.

Failure to respond to legitimate complaints would be further evidence that even senior rehabilitationists like Manoj Sivan either still don't understand the limits of this illness, or they do and participation in the study is itself an attempt at rehabilitation! It would also vividly highlight, as Andy points out, the attitudes towards patients.

Link to DHSC complaint portal if needed

 
Last edited:
Was still vexed by this, so posted on LinkedIN (as I think it is likely to do more good there than trying to contact the study team).

A brief critique of this communication with participants in an ME/CFS and Long Covid study.

Received an email today, screenshot below, 'requesting' I complete a number of questionnaires. Following are the issues I have with it:

* No clear indication of which study this is a reminder for.

* No welcoming note, thanking the participant for their previous effort.

* Duplicate effort needed from the participant (two questionnaires are to be completed twice).

* Declares that "Your XXX assessment is due today". The study is not due a participants input at any time, it gets it when they are able, especially with capacity limiting conditions such as ME/CFS.

* No link(s) back to the study page and/or contact information in case the participant needs it.

* A demand to complete the questionnaires via an app that I never installed, having completed the onboarding ones via the web version.

* An instruction to speak to my clinic to speak to a member of staff when, like the vast majority of people with ME/CFS, I receive no care for it, from a clinic or in any other form.

All of these issues give me the impression that the study team, who received over £1.3million of public money for their project, do not treat their participants with respect or understanding, and therefore means I have no faith that they will treat my data with respect.

I'm also aware that other patients have already attempted to communicate what I thought were reasonable concerns with the study team already, and have received no response, so no, I will not be contacting the team with these points.
 
Received this email today,
Oh joy, I received an almost identical email today, but now informing me that my responses are now overdue by a day. Makes me wonder if the app makers repurposed an existing app meant for debt collection - will they start charging me interest???

Another thing that occurred to me is that there is no unsubscribe link in either of the emails, which makes me wonder if AUTONOM-E is compliant with GPDR data regulations.
 
Sent the following via email to the study team today,

Please withdraw me from this study, and immediately stop AUTONOM-E from spamming me with daily demands that I complete your questionnaires.

For what it is worth, you might consider the following points:

The emails from AUTONOM-E have
  • No clear indication of which study this is a reminder for.
  • No welcoming note, thanking the participant for their previous effort.
  • Duplicate effort needed from the participant (two questionnaires are to be completed twice).
  • Declarations in the format "Your XXX assessment is due today". The study is not due a participants input at any time, it gets it when they are able, especially with capacity limiting conditions such as ME/CFS.
  • No link(s) back to the study page and/or contact information in case the participant needs it.
  • A demand to complete the questionnaires via an app that I never installed, having completed the onboarding ones via the web version. Also no link to the web version.
  • An instruction to speak to my clinic to speak to a member of staff when, like the vast majority of people with ME/CFS, I receive no care for it, from a clinic or in any other form.
  • No clear indication on how to unsubscribe from the reminder email.
All of these issues give me the impression of not treating the study participants with respect or understanding, and therefore means I have no faith that the study will treat my data in the same way.

I'm also aware that other patients have already attempted to communicate what I thought were reasonable concerns with the study team already, and have received no response.

I offer the points above based on my involvement experience as a member of the PPI Steering Group and the management team for DecodeME.

Look forward to swift confirmation of my withdrawal.
 
Thanks Andy. Excellent letter. It will be interesting to see what if any response you get.

Apologies everyone, I'm currently up to my eyes with other forum and non forum stuff, so haven't managed to sort out a complaint either to the Heritage team or the funders. I still intend to, but if someone else wants to draft something, that would be great.
 
Sent the following via email to the study team today,
And received the following automatic reply
Dear Sender,

Thank you for your interest in the HERITAGE Study.

We receive a high volume of enquiries, so while a member of the study team will review your message and respond as soon as possible, you may find that your question is already answered on our website Heritage: Health Effects fRom Infection sequelae: Tailoring services and Advancing GuidancE:
If after reviewing the information online you still have questions or need support, please reply to this email and we will get back to you.

Thank you again for your interest in supporting this research.

Kind regards,
HERITAGE Study Team
so I'm not sure I need to reply to their automatic reply with my withdrawal request or not....
 
And received the following automatic reply

so I'm not sure I need to reply to their automatic reply with my withdrawal request or not....

I read the automated message to your email to indicate that you do have to. What an incompetent setup. Not only do you have to duplicate two of the questionnaires, you also have to duplicate emailed requests!

Makes a mockery of this claim from the Abstract above:

Our previous study LOCOMOTION (2021-2024) funded by the NIHR for Long COVID enabled us to develop skills in standardising and improving quality of care, test a digital platform for collecting outcomes and analyse healthcare costs; these skills and resources can now be applied in this proposal (HERITAGE) to enable best value for money for the funder.
Their team now have to read your email, twice.

Muppets
 
Back
Top Bottom